F18.959 Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified

ICD10CM code

#### Name of the Condition
- Common Name: Inhalant Use Disorder with Psychotic Features
- Medical Term: Inhalant Use, Unspecified with Inhalant-Induced Psychotic Disorder, Unspecified

#### Summary
Inhalant Use Disorder with psychotic features is a mental health condition characterized by the misuse of inhalants—substances that produce chemical vapors—and the resulting development of psychosis, which includes delusions or hallucinations. This condition can significantly impact an individual's perception, emotions, and behavior.

#### Causes
- Inhalant use disorder is primarily caused by the repeated misuse of inhalants for their psychoactive effects.
- Inhalants are often everyday household items like glue, paint thinner, or aerosols.
- Genetic predisposition and environmental factors such as socio-economic challenges or peer pressure can also play a role.

#### Risk Factors
- Adolescents and young adults are more likely to experiment with inhalants.
- Individuals with a history of substance abuse or mental health disorders.
- Accessibility to inhalant products.
- Lack of proper supervision or guidance.

#### Symptoms
- Intense cravings or compulsive inhalant use.
- Hallucinations and delusions (psychotic symptoms).
- Coordination problems, dizziness, or lethargy.
- Unexplained behavioral changes such as aggression or mood swings.

#### Diagnosis
- Clinical evaluation including a thorough history of substance use.
- Psychological assessments to identify symptoms of psychosis.
- Toxicology screening may help confirm recent inhalant use.

#### Treatment Options
- Behavioral therapies like cognitive-behavioral therapy (CBT) and contingency management.
- Medications may be prescribed to manage psychosis, although specific treatments for inhalant dependency are limited.
- Inpatient rehabilitation programs for severe cases to ensure a substance-free environment.

#### Prognosis and Follow-Up
- Prognosis varies; with appropriate treatment, many individuals can recover, although long-term inhalant use can lead to persistent neurological damage.
- Regular follow-up with mental health professionals and support groups can prevent relapse and provide support.

#### Complications
- Respiratory or cardiac arrest from acute inhalant exposure.
- Long-term cognitive deficits or persistent psychosis.
- Social and legal consequences.

#### Lifestyle & Prevention
- Educating young people about the dangers of inhalant misuse.
- Safe storage of household products to prevent accidental or intentional misuse.
- Engaging in healthy activities and maintaining a supportive social network.

#### When to Seek Professional Help
- Experiencing or witnessing severe symptoms such as hallucinations, severe mood swings, or unexplained behavioral changes.
- If a person exhibits signs of overdose or acute distress after inhalant use, such as irregular heartbeat, fatigue, or confusion, urgent medical help is necessary.

#### Additional Resources
- National Institute on Drug Abuse (NIDA): [www.drugabuse.gov](https://www.drugabuse.gov)
- Substance Abuse and Mental Health Services Administration (SAMHSA): [www.samhsa.gov](https://www.samhsa.gov)

#### Tips for Medical Coders
- Ensure the specific code F18.959 is used for conditions where both inhalant use and psychotic disorder are unspecified.
- Double-check patient records to confirm the presence of psychotic symptoms alongside inhalant use.
- Avoid coding errors by distinguishing between similar disorders and clarifying any unspecified categories in the clinical documentation.

Similar Codes